- Home
- ISSC vs IPHA Comparison
ISSC vs IPHA Comparison
Compare ISSC & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISSC
- IPHA
- Stock Information
- Founded
- ISSC 1988
- IPHA 1999
- Country
- ISSC United States
- IPHA France
- Employees
- ISSC N/A
- IPHA N/A
- Industry
- ISSC EDP Services
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- ISSC Technology
- IPHA Health Care
- Exchange
- ISSC Nasdaq
- IPHA Nasdaq
- Market Cap
- ISSC 186.8M
- IPHA 160.1M
- IPO Year
- ISSC 2000
- IPHA 2019
- Fundamental
- Price
- ISSC $6.42
- IPHA $2.00
- Analyst Decision
- ISSC
- IPHA Strong Buy
- Analyst Count
- ISSC 0
- IPHA 1
- Target Price
- ISSC N/A
- IPHA $11.50
- AVG Volume (30 Days)
- ISSC 284.5K
- IPHA 657.4K
- Earning Date
- ISSC 02-13-2025
- IPHA 03-27-2025
- Dividend Yield
- ISSC N/A
- IPHA N/A
- EPS Growth
- ISSC 3.71
- IPHA N/A
- EPS
- ISSC 0.38
- IPHA N/A
- Revenue
- ISSC $53,858,686.00
- IPHA $36,202,722.00
- Revenue This Year
- ISSC $31.35
- IPHA N/A
- Revenue Next Year
- ISSC $16.39
- IPHA $93.37
- P/E Ratio
- ISSC $16.88
- IPHA N/A
- Revenue Growth
- ISSC 43.24
- IPHA N/A
- 52 Week Low
- ISSC $4.91
- IPHA $1.29
- 52 Week High
- ISSC $12.17
- IPHA $3.51
- Technical
- Relative Strength Index (RSI)
- ISSC 26.90
- IPHA 47.22
- Support Level
- ISSC $6.33
- IPHA $1.99
- Resistance Level
- ISSC $6.74
- IPHA $2.15
- Average True Range (ATR)
- ISSC 0.36
- IPHA 0.13
- MACD
- ISSC -0.03
- IPHA -0.03
- Stochastic Oscillator
- ISSC 5.42
- IPHA 3.53
About ISSC Innovative Solutions and Support Inc.
Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.